Stock listing
gettex:PSH0 Sernova Biotherapeutics Inc Aktie
German listing (gettex) of Sernova Biotherapeutics Inc · home listing TSX:SVA
Follow Sernova Biotherapeutics Inc into a list and get an email when it puts out news.
Home listing price · TSX:SVA
$0.105 CAD -0.005 (-4.5%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSX:SVA
- Day range
- $0.105 – $0.105 CADOct 30, 2026
- Volume
- 47,270 sharesOct 30, 2026
- Market cap
- $39.65M CADAt the close on Oct 30, 2026 · price × 377.6M shares outstanding
- 52-week range
- $0.090 – $0.200 CADLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $23,520 CADMedian day 94,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:SVA · Home | $0.105 CAD | -0.005 (-4.5%) | 47,270 | $0.105 | $0.105 | $0.105 | $0.110 | Close on Oct 30, 2026 |
| OTC:SEOVF | $0.08 USD | -0.01 (-11.1%) | 28,800 | $0.07 | $0.08 | $0.07 | $0.09 | Close on Oct 27, 2026 |
| Xetra:PSH0 | €0.071 EUR | +0.000 (+0.3%) | 16,855 | €0.071 | €0.077 | €0.062 | €0.071 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · TSX:SVA · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.105 | -0.005 | -4.5% | $0.105 | $0.105 | $0.105 | 47,270 | |
| $0.110 | 0.000 | 0.0% | $0.105 | $0.110 | $0.105 | 26,455 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 2,367 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.105 | 29,778 | |
| $0.110 | 0.000 | 0.0% | $0.105 | $0.110 | $0.105 | 70,630 | |
| $0.110 | 0.000 | 0.0% | $0.115 | $0.115 | $0.110 | 37,444 | |
| $0.110 | -0.010 | -8.3% | $0.120 | $0.120 | $0.110 | 67,500 | |
| $0.120 | +0.010 | +9.1% | $0.110 | $0.120 | $0.110 | 98,400 | |
| $0.110 | -0.010 | -8.3% | $0.120 | $0.120 | $0.110 | 90,000 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 34,900 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 167,000 | |
| $0.120 | 0.000 | 0.0% | $0.110 | $0.120 | $0.110 | 15,800 | |
| $0.120 | +0.010 | +9.1% | $0.120 | $0.120 | $0.110 | 130,200 | |
| $0.110 | -0.010 | -8.3% | $0.110 | $0.120 | $0.110 | 33,800 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 16,400 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 42,600 | |
| $0.120 | 0.000 | 0.0% | $0.120 | $0.120 | $0.120 | 73,700 | |
| $0.120 | +0.010 | +9.1% | $0.110 | $0.120 | $0.110 | 266,900 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.130 | $0.110 | 384,700 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 65,700 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.120 | $0.110 | 37,300 | |
| $0.110 | +0.020 | +22.2% | $0.100 | $0.120 | $0.100 | 1,433,900 | |
| $0.090 | 0.000 | 0.0% | $0.090 | $0.090 | $0.090 | 274,200 | |
| $0.090 | 0.000 | 0.0% | $0.090 | $0.100 | $0.090 | 284,200 | |
| $0.090 | 0.000 | 0.0% | $0.100 | $0.100 | $0.090 | 77,000 | |
| $0.090 | -0.010 | -10.0% | $0.100 | $0.100 | $0.090 | 721,200 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.110 | $0.100 | 455,400 | |
| $0.100 | -0.010 | -9.1% | $0.100 | $0.110 | $0.100 | 156,900 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.100 | 264,600 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.100 | 257,400 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 163,800 | |
| $0.110 | +0.010 | +10.0% | $0.110 | $0.110 | $0.100 | 199,000 | |
| $0.100 | -0.010 | -9.1% | $0.110 | $0.120 | $0.100 | 983,200 | |
| $0.110 | -0.030 | -21.4% | $0.140 | $0.140 | $0.110 | 1,227,000 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.150 | $0.140 | 547,500 | |
| $0.140 | 0.000 | 0.0% | $0.150 | $0.150 | $0.140 | 500,900 | |
| $0.140 | +0.010 | +7.7% | $0.150 | $0.150 | $0.140 | 350,500 | |
| $0.130 | +0.020 | +18.2% | $0.120 | $0.150 | $0.100 | 1,440,900 | |
| $0.110 | -0.010 | -8.3% | $0.120 | $0.120 | $0.110 | 65,300 | |
| $0.120 | 0.000 | 0.0% | $0.110 | $0.120 | $0.110 | 37,000 | |
| $0.120 | +0.010 | +9.1% | $0.110 | $0.120 | $0.110 | 5,000 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 112,500 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 40,800 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 71,700 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.120 | $0.110 | 51,500 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 4,000 | |
| $0.110 | 0.000 | 0.0% | $0.115 | $0.115 | $0.105 | 68,110 | |
| $0.110 | 0.000 | 0.0% | $0.115 | $0.115 | $0.110 | 40,202 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 121,600 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 44,400 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.100 | 103,100 | |
| $0.110 | +0.010 | +10.0% | $0.110 | $0.110 | $0.100 | 49,900 | |
| $0.100 | -0.010 | -9.1% | $0.110 | $0.110 | $0.100 | 232,600 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.120 | $0.110 | 5,100 | |
| $0.110 | -0.010 | -8.3% | $0.110 | $0.110 | $0.110 | 105,200 | |
| $0.120 | +0.010 | +9.1% | $0.110 | $0.120 | $0.110 | 134,600 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 11,600 | |
| $0.110 | -0.010 | -8.3% | $0.110 | $0.120 | $0.110 | 106,500 | |
| $0.120 | +0.010 | +9.1% | $0.120 | $0.120 | $0.110 | 209,000 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 132,500 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.120 | $0.110 | 163,700 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 276,600 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 71,600 | |
| $0.110 | 0.000 | 0.0% | $0.120 | $0.120 | $0.110 | 3,200 |
- Ticker
- gettex:PSH0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 19, 2026
Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
Latest deck · 2026
Merger or Acquisition (2026)
Merger or acquisition · 16 slides
Latest news
Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
Oct 19, 2026
Closed $0.12 (0.0%) on Oct 19, 2026
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
Oct 5, 2026
Closed $0.11 (0.0%) on Oct 5, 2026
Sernova Biotherapeutics to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference
Sep 25, 2026
Closed $0.09 (0.0%) on Sep 25, 2026
Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference
Sep 10, 2026
Closed $0.14 (0.0%) on Sep 10, 2026
Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
Sep 8, 2026
Closed $0.13 (+18.2%) on Sep 8, 2026
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
Jun 17, 2026
Closed $0.17 (+21.4%) on Jun 17, 2026
Sernova Biotherapeutics Announces Closing of Recently Approved Financings
Apr 23, 2026
Closed $0.17 (-5.6%) on Apr 24, 2026
Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders
Apr 9, 2026
Closed $0.18 (+12.5%) on Apr 9, 2026
Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
Mar 24, 2026
Closed $0.17 (0.0%) on Mar 24, 2026
2026 Q1 MD&A
Mar 16, 2026
Closed $0.16 (-5.9%) on Mar 16, 2026
Financings
Convertible notes and common stock purchase warrants of Seraxis
Oct 5, 2026
Closed: US$11.2M raised
Buyers: Dr. Steven Sangha / Arlo Investments; Jonathan Rigby; Will Rust
Insiders: Insiders participated, including Dr. Steven Sangha / Arlo Investments, Sernova management and Seraxis management
Use of proceeds: cGMP manufacturing of SR-02 islet cells and enrollment of T1D patients for the Phase 1/2 clinical trial
Decks
Merger or Acquisition (2026)
Merger or acquisition · 16 slides · 2026
Investor Presentation (February 2025)
Investor deck · 24 slides · February 2025
Investor Presentation (December 2024)
Investor deck · 31 slides · December 2024
Investor Presentation (September 2024)
Investor deck · 21 slides · Sep 12, 2024
Sernova Biotherapeutics Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 165 in all · newest Oct 19, 2026 · oldest 2015
- Decks
- 13 decks · latest 2026
Where Sernova Biotherapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:SVA · Home listing | TSX | Canada | CAD |
| OTC:SEOVF | OTC | United States | USD |
| Xetra:PSH0 | Xetra | Germany | EUR |
| Tradegate:PSH0 | Tradegate | Germany | EUR |
| gettex:PSH0 · This page | gettex | Germany | EUR |
| Cboe Canada:SVA | Cboe Canada | Canada | CAD |
| LS Exchange:A411DW | LS Exchange | Germany | EUR |
| Lang & Schwarz:A411DW | Lang & Schwarz | Germany | EUR |
| Munich:PSH0 | Munich | Germany | EUR |
| Dusseldorf:PSH0 | Dusseldorf | Germany | EUR |
| Hamburg:PSH0 | Hamburg | Germany | EUR |
| Stuttgart:PSH0 | Stuttgart | Germany | EUR |
| Frankfurt:PSH0 | Frankfurt | Germany | EUR |
| Hanover:PSH0 | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Sernova Biotherapeutics Inc.